Education
About Us
Working with TipRanks
Follow Us
Invion (AU:IVX)
ASX:IVX
IVX Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.10 - AU$0.43
Previous CloseN/A
Volume36.17K
Average Volume (3M)88.57K
Market Cap
$7.52M
Enterprise ValueAU$24.92M
Total Cash (Recent Filing)AU$3.43M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta-0.56
Next Earnings
Aug 29, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding77,478,386
10 Day Avg. Volume35,655
30 Day Avg. Volume88,572
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)11.40
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Invion News
PremiumCompany Announcements
Invion Limited Announces Virtual Extraordinary General Meeting
PremiumCompany Announcements
Invion Limited Announces Quotation of New Securities on ASX
PremiumCompany Announcements
Invion Limited Updates Securities Issuance Strategy
PremiumCompany Announcements
Invion Limited Announces Quotation of New Securities on ASX
PremiumCompany Announcements
Invion Limited Announces Proposed Securities Issue---
IVX FAQ
What was Invion’s price range in the past 12 months?
Invion lowest share price was AU$0.10 and its highest was AU$0.43 in the past 12 months.
What is Invion’s market cap?
Invion’s market cap is $7.52M.
When is Invion’s upcoming earnings report date?
Invion’s upcoming earnings report date is Aug 29, 2025 which is in 133 days.
How were Invion’s earnings last quarter?
Invion released its earnings results on Feb 28, 2025. The company reported -AU$0.028 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.028.
Is Invion overvalued?
According to Wall Street analysts Invion’s price is currently Overvalued.
Does Invion pay dividends?
Invion does not currently pay dividends.
What is Invion’s EPS estimate?
Invion’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Invion have?
Invion has 77,478,386 shares outstanding.
What happened to Invion’s price movement after its last earnings report?
Invion reported an EPS of -AU$0.028 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Invion?
Currently, no hedge funds are holding shares in AU:IVX
---
Invion Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:IVX Sentiment 100%
Sector Average 69%
Sector Average 69%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-91.00%
12-Months-Change
Fundamentals
Return on Equity
-44.03%
Trailing 12-Months
Asset Growth
-31.52%
Trailing 12-Months
Company Description
Invion
Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company was incorporated in 2000 and is headquartered in Melbourne, Australia.
---
Technical Analysis
Actinogen Medical Limited
―
Biotron Limited
―
Imugene Limited
―
Patrys Limited
―
Race Oncology Ltd.
―
---